Vivus (VVUS)
Vivus Cash and ST Investments: 333.40M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
VVUS Cash and ST Investments Rankings
| Overall | 75th percentile | 1067 of 4368 |
| Sector | 84th percentile | 79 of 506 in Healthcare |
| Industry | 88th percentile | 18 of 160 in Biotechnology |
VVUS Cash and ST Investments Range, Past 5 Years
| Minimum | 53.15M | Jun 2007 |
| Maximum | 333.40M | Mar 2012 |
| Average | 170.29M |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these VVUS related companies
VVUS News
@epime7heus $arna $vvus .. Logical thing to do, Fda needs to give doctors and patients a choice. So i think they will both get approved
about 13 hours ago by LionShare
about 13 hours ago by LionShare
@Bleedblue $VVUS has other drugs, all $ARNA eggs are in weight loss basket and has all the same safety concerns and problems $VVUS does
about 14 hours ago by epime7heus
about 14 hours ago by epime7heus
$VVUS has problems, $ARNA does not. panel vote means nothing and were only talking 2 votes dif.
about 14 hours ago by Bleedblue
about 14 hours ago by Bleedblue
@Bleedblue $VVUS is standing in $ARNA's way with a more unanimous panel vote then ARNA got so VVUS is more likely to get approved if only 1
about 14 hours ago by epime7heus
about 14 hours ago by epime7heus
@SomeGuy900 JMO from facts and analysis,no secrets. MO is also $VVUS will not be approved for some time. ARNA will already be in motion.
about 15 hours ago by svtechie
about 15 hours ago by svtechie
@low_level_owl $ARNA The initial draft of the $VVUS REMS was submitted on Dec. 28, 2009; it was likely discussed for 6 to 12 months earlier
about 16 hours ago by SlownSteady
about 16 hours ago by SlownSteady
@slownsteady...$ARNA much smarter in marketing and distribution than $VVUS. We have it they dont...sux for $VVUS
about 16 hours ago by svtechie
about 16 hours ago by svtechie
RT @SlownSteady @Njodogg $ARNA The $VVUS announcement came after regular trading hours.>An example of how the "man" screws the retailer
about 21 hours ago by RickPalmer907
about 21 hours ago by RickPalmer907
@Njodogg $ARNA The $VVUS announcement came after regular trading hours.
about 21 hours ago by SlownSteady
about 21 hours ago by SlownSteady
When the announced $vvus pufda delay was it during market hours or AH? Curious stalking $arna
about 21 hours ago by Njodogg
about 21 hours ago by Njodogg
$ARNA - benzinga article out against $VVUS favorable to $ARNA market cap.
about 22 hours ago by jackofalltrade
about 22 hours ago by jackofalltrade
@randal $ARNA It will not happen like $VVUS. No hint of a REMS for lorcaserin.
about 2 days ago by SlownSteady
about 2 days ago by SlownSteady
@markf Hey, the $VVUS PDUFA is 7-17-2012, i typed wrong in my previous message
about 2 days ago by damnmaxims
about 2 days ago by damnmaxims
Needham & Company Reiterates a 'Buy' on Vivus (VVUS); Expect Approval of Qnexa by the PDUFA Date
May 08, 8:23AM Street Insider
May 08, 8:23AM Street Insider
VIVUS Announces Date of First Quarter 2012 Financial Results and Conference Call
May 01, 6:45AM GlobeNewswire
May 01, 6:45AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| VVUS | 23.70 | -1.09 | -4.40% | 2.429B |
| VVTV | 1.69 | -0.05 | -2.87% | 84.48M |
| VVR | 4.65 | +0.02 | +0.43% | |
| VVI | 17.37 | -0.34 | -1.92% | 356.86M |
| VVC | 28.68 | -0.64 | -2.18% | 2.404B |
| VV | 58.84 | -1.26 | -2.10% | |
| VUG | 64.75 | -1.56 | -2.35% | |
| VTV | 52.71 | -1.06 | -1.97% | |
| VTUS | 9.86 | -0.25 | -2.47% | 125.47M |
| VTROD | 1.30 | +0.00 | +0.00% |
